ZKSCAN1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.797400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.761800E-01
Normal-vs-Stage2
8.367400E-01
Normal-vs-Stage3
1.089990E-01
Normal-vs-Stage4
1.516840E-01
Stage1-vs-Stage2
4.403600E-02
Stage1-vs-Stage3
3.141600E-02
Stage1-vs-Stage4
8.043200E-01
Stage2-vs-Stage3
1.147970E-01
Stage2-vs-Stage4
1.833200E-01
Stage3-vs-Stage4
4.324600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.747600E-01
Normal-vs-AfricanAmerican
5.195600E-01
Normal-vs-Asian
7.469200E-01
Caucasian-vs-AfricanAmerican
7.572600E-01
Caucasian-vs-Asian
1.446820E-01
AfricanAmerican-vs-Asian
1.903440E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.588000E-01
Normal-vs-Female
8.050400E-01
Male-vs-Female
7.463600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.702400E-01
Normal-vs-Age(41-60Yrs)
5.851200E-01
Normal-vs-Age(61-80Yrs)
8.829200E-01
Normal-vs-Age(81-100Yrs)
9.039600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.036000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.303400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.056800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.388400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.244600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.412200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.407600E-01
Normal-vs-Daily Drinker
7.971600E-01
Normal-vs-Weekly Drinker
9.743200E-01
Normal-vs-Occasional Drinker
5.095800E-01
Normal-vs-Social Drinker
4.770200E-01
Non Drinker-vs-Daily Drinker
6.911600E-01
Non Drinker-vs-Weekly Drinker
9.648000E-01
Non Drinker-vs-Occasional Drinker
1.071030E-01
Non Drinker-vs-Social Drinker
1.124370E-01
Daily Drinker-vs-Weekly Drinker
7.501000E-01
Daily Drinker-vs-Occasional Drinker
7.768300E-02
Daily Drinker-vs-Social Drinker
8.135800E-02
Weekly Drinker-vs-Occasional Drinker
1.869950E-01
Weekly Drinker-vs-Social Drinker
1.755590E-01
Occasional Drinker-vs-Social Drinker
9.594000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.515800E-01
Normal-vs-Grade 2
2.476000E-02
Normal-vs-Grade 3
6.084100E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.956800E-01
Grade 1-vs-Grade 3
5.533800E-01
Grade 1-vs-Grade 4
2.515800E-01
Grade 2-vs-Grade 3
1.421160E-01
Grade 2-vs-Grade 4
2.476000E-02
Grade 3-vs-Grade 4
6.084100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.982400E-01
Normal-vs-NonDiabetic
8.131200E-01
Diabetic-vs-NonDiabetic
2.876600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.155800E-01
Normal-vs-NoPancreatitis
8.282200E-01
Pancreatitis-vs-NoPancreatitis
7.387600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.091400E-01
Normal-vs-N1
8.641400E-01
N0-vs-N1
2.824200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.557800E-01
Normal-vs-TP53-NonMutant
4.688800E-01
TP53-Mutant-vs-TP53-NonMutant
6.474200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
